An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B. by Winter, G, Rix, U, Lissat, A, Stukalov, A, Müllner, M, Bennett, K, Colinge, J, Nijman, S, Kubicek, S, Kovar, H, Kontny, U, Superti-Furga, G

Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. by Huber, K, Salah, E, Radic, B, Gridling, M, Elkins, J, Stukalov, A, Jemth, A, Göktürk, C, Sanjiv, K, Strömberg, K, Pham, T, Berglund, U, Colinge, J, Bennett, K, Loizou, J, Helleday, T, Knapp, S, Superti-Furga, G

Artemisinins target GABAA receptor signaling and impair α cell identity. by Li, J, Casteels, T, Frogne, T, Ingvorsen, C, Honoré, C, Courtney, M, Huber, K, Schmitner, N, Kimmel, R, Romanov, R, Sturtzel, C, Lardeau, C, Klughammer, J, Farlik, M, Sdelci, S, Vieira, A, Avolio, F, Briand, F, Baburin, I, Májek, P, Pauler, F, Penz, T, Stukalov, A, Gridling, M, Parapatics, K, Barbieux, C, Berishvili, E, Spittler, A, Colinge, J, Bennett, K, Hering, S, Sulpice, T, Bock, C, Distel, M, Harkany, T, Meyer, D, Superti-Furga, G, Collombat, P, Hecksher-Sørensen, J, Kubicek, S